Unlike the general population, patients on maintenance hemodialysis have both traditional and nontraditional risk factors that put them at high cardiovascular risk, despite use of standard lipid and ...

Type 1 diabetes with CKD is understudied with no advancement of therapy options since the 1990s. The FINE-ONE phase 3 trial addresses a high, unmet need for treatments.

Any aspirin use linked to lower hazards of MI, ischemic stroke, with greater benefit in high-frequency use group.

Longer-term exposure to testosterone therapy was associated with an increased risk for major adverse cardiovascular events among men.

Lower risk for MCI and dementia also seen with moderate, high cardiovascular health in those with high polygenic risk score.

Study reveals 5.05 percent of individuals carry pathogenic/likely pathogenic variants in in large, unselected U.S. population.

The small trial will start with six people and may expand to 50 people if early results are safe. (HealthDay News) — A first-of-its-kind clinical trial is beginning in the United States to see if pig ...

Topline results were announced from two phase 3 trials evaluating combination regimens containing belzutifan (Welireg) for the treatment of renal cell carcinoma.